ReGeneraTing Agents (RGTA®) technology combined with antibiotics
improves outcomes for infections in the upper limb
In this case series, four patients developed or presented with severe
infections. In addition to antimicrobial therapy, they were treated with
a new matrix therapy technology called CACIPLIQ20®. CACIPLIQ20® markedly
improved the outcomes of all cases in terms of healing times and range
of motion despite healing by secondary intention.